Serotonin antibodies in relation to immune activation in major depression

Human Psychopharmacology

Volumn 12, Issue 5, 1997, Pages 453-458

  Sluzewska, A ^a   Samborski, W ^a   Sobieska, M ^a   Klein, R ^b   Bosmans, E ^c   Rybakowski, J K ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Eurogenetics   (Belgium)

Author keywords

Acute phase proteins; Gangliosides; IL 6; Serotonin antibodies

Indexed keywords

ACUTE PHASE PROTEIN; ANTIDEPRESSANT AGENT; GANGLIOSIDE; INTERLEUKIN 6;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNITY; MALE; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL;

EID: 0030829173     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199709/10)12:5<453::AID-HUP888>3.0.CO;2-4     Document Type: Article

References (39)

1. Abraham, K. I., Ieni, J. R. and Meyerson, L. R. (1987). Purification and properties of human plasma endogenous modulator for platelet tricyclic binding/serotonine transport complex. Biochemica Biophysica Acta, 923, 8-21.
2. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association, Washington, D.C.
3. Balkwill, F. R. (1993). Cytokines in health and disease. Immunology Today, 14, 149-150.
4. Balkwill, F. R. and Burke, F. (1989). The cytokine network. Immunology Today, 10, 299-303.
5. Baumann, H., Richards, C. and Gauldie, J. (1987). Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase proteins in human hepatoma (Hep G2) cells. Journal of Immunology, 15, 4122-4128.
6. Bode, L., Durrwald, R., Rantam, F. A., Ferszt, R. and Ludwig, H. (1996). First isolation of infectious human Borna disease virus from patients with mood disorders. Molecular Psychiatry, 1, 200-212.
7. Bog-Hansen, T. C. (1973). Crossed immuno-affinoelectrophoresis: an analytical method to predict the result of affinity chromatography. Analytical Biochemistry, 56, 480-488.
8. Campbell, I. L. and Chiang, Ch-Sh. (1995). Cytokine involvement in central nervous system disease: Implications from transgenic mice. In: Stress: Basic Mechanisms and Clinical Implications, Chrousou, G. P., McCarty, R., Pacak, K., Cizza, G., Sternberg, E., Gold, Ph. W. and Kwetnewsky, R. (Eds), Annals N.Y. Academy of Sciences, vol. 771, pp. 301-312.
9. Cavallo, M. G., Pozzilli, P. and Thorpe, R. (1994). Cytokines and autoimmunity. Clinical and Experimental Immunology, 96, 1-7.
10. Cohen, I. R. and Cooke (1986). Natural antibodies might prevent autoimmune disease. Immunology Today, 7, 363-364.
11. Durand, G. (1989). Glycan variations of human alpha-1-acid glycoprotein modulate the biology of macrophages. Progress in Clinical Biology Research, 300, 247-252.
12. Fishman, P. H. (1988). Gangliosides as cell surface receptors and transducers of biological signals. In: New Trends in Ganglioside Research: Neurochemical and Neuroregenerative Aspects, Ledeen, R. W., Hogan, E. L., Tettamanti, G., Yates, A. J. and Yu, R. R. (Eds), Liviana Press, Padova, pp. 183-217.
13. Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-62.
14. Heinrich, P. C., Castell, J. V. and Andus, T. (1990). Review article: interleukin-6 and the acute phase response. Biochemistry Journal, 265, 621-636.
15. Irwin, M., Patterson, T., Smith, T. L., Caldwell, C., Brown, S. A., Gillin, J. C. and Grant, I. (1990). Reduction of immune function in life stress and depression. Biological Psychiatry, 27, 22-30.
16. Joyce, P. R., Hawes, C. R. and Mulder, R. T. (1992). Elevated levels of acute phase plasma proteins in major depression. Biological Psychiatry, 32, 1035-1041.
17. Klein, R., Richter, C. and Berg, P. A. (1991). Antibodies against central nervous system tissue (anti-CNS) detected by ELISA and Western blotting: marker antibodies for neuropsychiatric manifestations in connective tissue diseases. Autoimmunity, 10, 133-144.
18. Kremer, J. M. H., Wilting, J. and Janssen, L. H. M. (1988). Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacological Review, 40, 1-47.
19. Laurell, C. B. (1966). Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Annals of Biochemistry, 15, 45-52.
20. Mackiewicz, A. and Mackiewicz, S. (1986). Determination of lectin-sugar dissociation constants by agarose affinity electrophoresis. Annals of Biochemistry, 56, 480-484.
21. Mackiewicz, A., Pawłowski, T., Mackiewicz-Pawłowska, A., Wiktorowicz, K. and Mackiewicz, S. (1987). Microheterogeneity forms of alpha-1-acid glycoprotein as indicator of rheumatoid arthritis activity. Clinica Chimica Acta, 163, 185-190.
22. Maes, M. (1993). Acute phase protein alterations in major depression: A review. Review of Neuroscience, 4, 407-416.
23. Maes, M., Bosmans, E., Suy, E., Vandervorst, C., Dejonckheere, C. and Raus, J. (1991). Antiphospholipid, antinuclear, Epstein-Barr and cytomegalovirus antibodies and soluble interleukine-2 receptor in depressive patients. Journal of Affective Disorders, 21, 133-140.
24. Maes, M., Meltzer, H. Y. and Bosmans, E. (1995). Increased plasma levels of interleukin-6, soluble interleukin-2 and transferrin receptors in major depression. Journal of Affective Disorders, 34, 301-309.
25. Maes, M., Scharpe, S., Bosmans, E., Vandewoude, M., Suy, E., Uyttenbroeck, W., Cooreman, W., Vandervorst, C. and Raus, J. (1992b). Disturbances in acute phase proteins during melancholia: additional evidence for presence of inflammatory process during that illness. Progress in Neuropsychopharmacology and Biological Psychiatry, 16, 501-515.
26. Maes, M., Scharpe, S., Van Grootel, L., Uyttenbroeck, W., Cooreman, W., Cosyns, P. and Suy, E. (1992a). Higher alpha-1-antitrypsin, haptoglobin, celurö plasmin and lower retinol protein plasma levels during depression. Further evidence for the existence of an inflammatory process during that illness. Journal of Affective Disorders, 24, 183-192.
27. Pos, O., Van der Stelt, M. E. and Wolbik, G. J. (1990). Changes in the serum concentration and glycosylation of human alpha-1-acid glycoprotein and alpha-1-protease inhibitor in severely burned patients: relation to interleukine-6 levels. Clinical and Experimental Immunology, 82, 579-582.
28. Schott, K., Batra, A., Klein, R., Bartels, M., Koch, W. and Berg, P. A. (1992) Antibodies against serotonin and gangliosides in schizophrenia and major depressive disorder. European Psychiatry, 7, 209-212.
29. Schott, K. and Batra, A. (1995). No antibody binding to serotonin in serum of patients with paranoid schizophrenia and major depressive disorder. European Psychiatry, 10, 372.
30. Sluzewska, A., Rybakowski, J. K., Laciak, M., Mackiewicz, A., Sobieska, M. and Wiktorowicz, K. (1995a) Interleukin-6 levels in depressed patients before and after treatment with fluoxetine. Annals of NY Academy of Science, 762, 474-477.
31. Sluzewska, A., Rybakowski, J. K., Sobieska, M., Bosmans, E., Pollet, H. and Wiktorowicz, K. (1995b). Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression, 3, 170-175.
32. Sluzewska, A., Rybakowski, J. K., Sobieska, M. and Wiktorowicz, K. (1996a). Concentration and microheterogeneity glycophorms of alpha-1-acid glycoprotein in major depression. Journal of Affective Disorders, 39, 149-155.
33. Sluzewska, A., Rybakowski, J., Bosmans, E., Sobieska, M., Berghans, R., Maes, M. and Wiktorowicz, K. (1996b). Indicators of immune activation in major depression. Psychiatry Research, 63(3), 161-167.
34. Sluzewska, A., Rybakowski, J. and Sobieska, M. (1996c). Immune activation in endogenous depression. Psychiatria Polska, 5, 771-782.
35. Song, C. and Leonard, B. E. (1993). Changes in plasma proteins in depressed patients and rodent model of depression. Neuropsychopharmacology, 9, 106S.
36. Song, C., Dinan, T. and Leonard, B. E. (1994). Changes in immunoglobulines, component and acute phase proteins levels in depressed patients and normal controls. Journal of Affective Disorders, 30, 283-288.
37. Thase, M. E. and Rush, A. J. (1995). Treatment-resistant depression. In F. E. Bloom and D. J. Kupfer (Eds), Psychopharmacology, the Forth Generation of Progress. Raven Press, New York, pp. 1081-1098.
38. Turner, G. A. (1992). N-glycosylation of serum proteins in disease and its investigation using lectins. Clinica Chemica Acta, 208, 149-171.
39. Van Dijk, W., Turner, G. A. and Mackiewicz, A. (1994) Changes in glycosylation of acute phase proteins in health and disease: occurrence regulation and function. Glycosylation & Disease, 1, 5-14.